Literature DB >> 10950979

Activation of cellular interferon-responsive genes after infection of human cells with herpes simplex virus type 1.

Mary Jane Nicholl1, Laurence H Robinson1, Chris M Preston1.   

Abstract

Previous studies have shown that infection of human fibroblasts with human cytomegalovirus (HCMV) results in activation of cellular interferon-responsive gene expression. We demonstrate here that infection of human fibroblasts with herpes simplex virus type 1 (HSV-1) in the absence of de novo protein synthesis also induces the expression of interferon-responsive genes. Five genes tested (encoding ISG54, IFI56, ISG15, 9-27 and MxA) were activated by infection with HSV-1, although the degree of response varied between the individual genes. HSV-1 was a less efficient inducer than HCMV. The effect was a consequence of binding of the virus particle to the cell surface or of the presence of virion components within the infected cell. Induction was mediated by a pathway other than the mechanism through which interferon-alpha mediates its effects on cellular gene expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10950979     DOI: 10.1099/0022-1317-81-9-2215

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  68 in total

1.  Herpes simplex virus triggers and then disarms a host antiviral response.

Authors:  K L Mossman; P F Macgregor; J J Rozmus; A B Goryachev; A M Edwards; J R Smiley
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Nuclear translocation and activation of the transcription factor NFAT is blocked by herpes simplex virus infection.

Authors:  E S Scott; S Malcomber; P O'Hare
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

3.  Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral infection.

Authors:  Kasey M Eidson; William E Hobbs; Brian J Manning; Paul Carlson; Neal A DeLuca
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

4.  Genetic editing of herpes simplex virus 1 and Epstein-Barr herpesvirus genomes by human APOBEC3 cytidine deaminases in culture and in vivo.

Authors:  Rodolphe Suspène; Marie-Ming Aynaud; Stefanie Koch; David Pasdeloup; Marc Labetoulle; Barbara Gaertner; Jean-Pierre Vartanian; Andreas Meyerhans; Simon Wain-Hobson
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

5.  The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes.

Authors:  Rongtuan Lin; Ryan S Noyce; Susan E Collins; Roger D Everett; Karen L Mossman
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

Review 6.  Herpes simplex virus virion host shutoff protein: immune evasion mediated by a viral RNase?

Authors:  James R Smiley
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

7.  Full resistance of herpes simplex virus type 1-infected primary human cells to alpha interferon requires both the Us11 and gamma(1)34.5 gene products.

Authors:  Matthew Mulvey; Vladimir Camarena; Ian Mohr
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  In situ expression of 15 kDa interferon alpha responsive gene in the developing tooth germ of the mouse lower first molar.

Authors:  Merina Akhter; Ieyoshi Kobayashi; Tamotsu Kiyoshima; Kengo Nagata; Hiroko Wada; Yukiko Ookuma; Hiroaki Fujiwara; Jyun-Ya Honda; Hidetaka Sakai
Journal:  J Mol Histol       Date:  2010-07-11       Impact factor: 2.611

9.  Up-regulation of interferon-stimulated gene15 and its conjugates by tumor necrosis factor-α via type I interferon-dependent and -independent pathways.

Authors:  Kongthawat Chairatvit; Ariyaphong Wongnoppavich; Sirinthip Choonate
Journal:  Mol Cell Biochem       Date:  2012-06-23       Impact factor: 3.396

10.  Herpes simplex virus 1 tegument protein US11 downmodulates the RLR signaling pathway via direct interaction with RIG-I and MDA-5.

Authors:  Junji Xing; Shuai Wang; Rongtuan Lin; Karen L Mossman; Chunfu Zheng
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.